News LoveBug Probiotics Co-Founder Reunites with Fellow Booth Alum for First Venture Round Co-founded by University of Chicago Booth School of Business alum Ben Harris, MBA ’09, and Ashley Harris, LoveBug Probiotics – a probiotic supplements company geared toward mothers and children –...
News Scientists and Business Leaders Tackle Shared Challenges at First-ever Chicago Microbiome Conference What singular topic has the ability to unite researchers studying skin care, cancer, irritable bowel disease, and Alzheimer’s disease? The microbiome – the study of the bacteria, fungi, and other...
News Patent of the Week: A More Functional Freeze-Dried Formulation Lactic acid bacteria has uses in the food and feed industries, as well as in medicine and chemistry applications. The bacteria is used as a source of probiotics and as...
News 24 Startups Accepted into the 2023 Alumni New Venture Challenge The Polsky Center for Entrepreneurship and Innovation is pleased to announce the 24 startups accepted into the 2023 Alumni New Venture Challenge (ANVC), a global competition dedicated to supporting all...
Technology A Microbial Consortia That Depresses Klebsiella Pneumoniae Drug-resistant Enterobacteriaceae (particularly K. pneumoniae) are a growing cause of hospital-acquired infections, pneumonia, and antibiotic failure. Broad-spectrum antibiotics exacerbate dysbiosis and resistance, while fecal microbiota transplant lacks standardization, mechanistic clarity,…
Technology Defined Live Biotherapeutic Compositions That Restore Depleted Gut Metabolites To Improve Outcomes In Liver Disease Patients Patients with advanced liver disease, transplant recipients, and other critically ill populations frequently experience profound microbiome dysbiosis due to antibiotics and hospitalization. This dysbiosis is characterized by loss of microbial…
